Tech billionaires aiming to disrupt death

On the biotech front, things may be catching up more quickly than you think, writes Izabella Kaminska

©Fetal Medicine Unit, St. George’s Hospital NH

Diagnostics: DNA to deliver safer pregnancies

A cell-free DNA diagnosis technique detects genetic disorders in the foetus without invasive prenatal testing

Obama’s climate change legacy at risk

Oklahoma attorney-general fights White House on role of EPA

Start-up aims to make pipe dream a reality

Underground parcel network is part of scheme to inject technology into the transport sector

Ontario joins cap-and-trade programme

Move may encourage other regions to join emissions trading system

An artist's representation of hydrogen protons going through a sheet of graphene

UK group signs Japan graphene deal

Plan shows progress in development of ‘wonder’ material

Pharma combats diversion of cheap drugs

Invest or stagnate

Policy makers’ response to economic uncertainty needs to minimise harm, writes Alan Beattie

Oncology: cancer checkpoint

Immunotherapy is the most exciting development in oncology for decades

©Katie Preece

Volcanology: the mysteries of mega-eruptions

The size and date of past eruptions may shed light on future hazards

Psychology: does gaming really cause bad behaviour?

Are video games a cause for moral panic?

Dyson aims to keep it all in the family

Sir James signals son will take over when he steps down

Atom Bank keeps faith with wearable tech

Challenger optimistic that customer resistance will fade

3D printing pioneer backed by Autodesk

Carbon3D gains $10m backing from US-listed software group

Rise of the 3D printing machines

‘Terminator’ technology threatens manufacturing pioneers

Fund boosts Wales biotech sector

Welsh government investment fund backs proton beam cancer treatment centre in Cardiff

Indian ecommerce start-ups eye cricket

Tech groups look to glitzy IPL tournament to raise their profiles

Big pharma uses biotechs in cancer race

Industry giants forge alliances to push ahead in immunotherapies

Scaling up before the BBC gadget giveaway

The device-debunking Technology Will Save Us believes in its name

How phone calls help India fight TB

E-vouchers help provide effective medicines to sufferers

Workplace wellness has a long way to go

Leadership is lacking in bid to boost employee health

World watches Japan’s ageing citizens

Nation turns to digital medical records to improve wellbeing

Internet of things speeds health delivery

Technology allows patients to have the kind of monitoring once reserved for urgent cases

Gene therapy drug adds to costs debate

Expense adds to debate over affordability

Christophe Weber: Takeda’s outsider

Investors back proton-beam cancer centres

Biotech entrepreneur leads push to open clinics a year before NHS

Cameras roll on a virtual reality future

Video is being transformed by long-anticipated VR technology

Key economies miss climate pledge date

Nations that did set out targets account for quarter of emissions

Business pioneers in technology

The industry’s rapid cycles have been an opportunity for young outsiders to bring in a fresh perspective

Pharma dealmaking helps lift US stocks

Energy sector powers ahead in spite of slide in crude

City jobs lost in spite of upbeat outlook

Banks respond to pressure on profits and need to streamline operations

City accused of failing life sciences

Sector too dependent on GSK and AstraZeneca, says top scientist

Brics banker goes to war on superbugs

Jim O’Neill is leading the drive to tackle drug-resistant superbugs

Dr Google assists in robotic surgery

Collaboration with J&J on operating table systems

Parasitology: Parasites as protectors

A new strategy could have an impact on malaria

Mycology: fungi that glow in the dark

Bioluminescence helps Brazilian mushroom attract insects

Genetics: fat is a fishy issue

How genetically modified fish provide insight on body fat storage in humans

Actavis rewrites ‘big pharma’ playbook

Are big, lean dealmakers running out of targets?

Drugs groups unite to mine genetic data

Groups to join 100,000 Genomes Project

Moulton-backed RedX Pharma to list on Aim

UK life science industry shows sign of life beyond southeast

SHARE THIS QUOTE